The a2-adrenergic Agonist Sexmedetomidine as a Treatment for Nerve Agent-induced Status Epilepticus

Date: Thursday, 10 06, 2016; Speaker: Hilary S. McCarren, PhD, US Army Medical Research Institute of Chemical Defense; Building: USUHS
Source: NIH Calendar of Events - Category: American Health Source Type: events